Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy.
about
Thrombophilia and pregnancyLow-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM).Preventive effects of folic acid supplementation on adverse maternal and fetal outcomes.Hemostatic problems before, during and after delivery.Cerebrovascular disorders in children with the factor V Leiden mutation.Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development.MTHFR (C677T) polymorphism and PR (PROGINS) mutation as genetic factors for preterm delivery, fetal death and low birth weight: A Northeast Indian population based studyChanges in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis?Inherited metabolic diseases and pregnancy.Thrombophilia and damage of kidney during pregnancyAssociations between 2 polymorphisms in the methylenetetrahydrofolate reductase gene and placental abruption.Placental histopathologic features in patients with thrombophilic mutations.Pregnancy and thrombophilia.Homocysteine: biomarker or cause of adverse pregnancy outcome?Thrombophilia is not associated with an increase in placental abnormalities in women with intra-uterine fetal death.Maternal methylenetetrahydrofolate reductase (MTHFR) homozygosity and neonatal outcome: follow-up of 42 pregnancies at risk.Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study.The influence of erythrocyte folate and serum vitamin B12 status on birth weight.An investigation of folate-related genetic factors in the determination of birthweight.
P2860
Q24801115-5BFCA102-1843-43B6-A2B6-B0AB672D469AQ30833556-E6318AFA-0C9B-45F7-AE9D-1389E240C1F7Q33632110-B743E859-CF53-406A-8972-8BDB8C5818D8Q34305396-4CC3DCFE-A117-4269-A18C-A869B28DB289Q34415810-C776F827-39D7-46AC-85A7-9737E17ED0F7Q34595681-4412E487-8E35-4BDE-B12A-614DC6703079Q35087360-50942C21-AAAA-4182-92D6-E6D806FC94D4Q35542199-06A09C03-BD24-4C9B-819A-56E04DC09F6EQ36016747-CE8445B2-94FD-4371-BE90-426A6F18FAE1Q36101176-7364FF59-2A6B-44BC-8532-1D25DFC23CCFQ36156053-33F07D62-24A2-4688-A7E0-48AB723C83FCQ36793046-B95D33A8-638B-4984-A3BE-5CEE818BBAD3Q36867306-B7242ACA-695E-4CEA-8700-79384308B47BQ37755146-94E1C9E4-3F17-4BB0-82C7-F6612E983965Q40526718-94E2AFF4-86B4-4582-BDDF-B981EE3E734DQ43112895-E1EE4809-2E69-48BF-80D9-594DED8D8082Q44959180-4F836473-2F2B-416C-BDBF-EF976F4F8ADCQ46563631-3DA5A46E-1F0E-4ACD-9575-21675F7719F8Q46663003-D0822A67-85D9-404C-9582-727A9F679285
P2860
Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Hyperhomocysteinemia and other ...... n with placental vasculopathy.
@en
Hyperhomocysteinemia and other ...... n with placental vasculopathy.
@nl
type
label
Hyperhomocysteinemia and other ...... n with placental vasculopathy.
@en
Hyperhomocysteinemia and other ...... n with placental vasculopathy.
@nl
prefLabel
Hyperhomocysteinemia and other ...... n with placental vasculopathy.
@en
Hyperhomocysteinemia and other ...... n with placental vasculopathy.
@nl
P2093
P2860
P1476
Hyperhomocysteinemia and other ...... n with placental vasculopathy.
@en
P2093
Monnens LA
Nováková I
Verbruggen B
van der Molen EF
P2860
P304
P356
10.1111/J.1471-0528.2000.TB13341.X
P50
P577
2000-06-01T00:00:00Z